Chief Financial Officer

Albert J. Pavucek, Jr., MBA

Collegeville, PA **426 ● Cell: 484-***-****

********@*****.*** ● www.linkedin.com/in/alpavucek

PROFILE

CFO Executive Management Finance

Strategic CFO with over 30 years of experience generating significant positive financial and operational results and increased company/shareholder value in a variety of public and private companies and industries, including large global companies and small startup ventures. Experience includes equity offerings; debt facilities; working effectively with boards of directors, investors, Wall Street analysts, investment banks; and conducting investor presentations and road shows. Known for ability to both efficiently manage day-to-day financial operations and contribute to the profitability of a company as a strategic business partner to the CEO and other executive management. Key skills and areas of expertise include:

Driving Profitability and Growth

M&A Activity and Integration; Corporate Restructuring; Turnaround Situations.

Private Equity and Public Company CFO experience.

International Financial Operations and Reporting

Accounting, Treasury and Audit

Cash Flow/Working Capital Management

Board, Investor and Analyst Relations

Developing and Implementing Policies and Procedures

Building and Leading Effective High-Performance Teams

Managing Banking, Auditor and Key Vendor Relationships

Excellent Contract Negotiation Skills

Private Equity Experience

EXPERIENCE

INIZIO ENGAGE (formerly ASHFIELD HEALTHCARE LLC), Global Commercial & Clinical Services, Fort Washington, PA 2017 – Present

$900+ million wholly owned subsidiary of UDG Healthcare plc, one of the largest healthcare services companies in the world (now under private equity firm CD&R as of August 2021). My division consists of healthcare commercialization services for 28 countries and Business Units, with up to 6,000 FTEs.

SVP and Global Chief Financial Officer

Oversaw financial operations for a Division with Business units including Commercial, Clinical, Market Access, Medical Information, Pharmacovigilance, Data/Analytics, and Strategic Consulting.

Lead all areas of Finance, consisting of twenty-eight global business units. Direct overall financial policies, overseeing accounting, finance, payroll, credit, audit, and treasury (Working Capital and Cash Flows).

Significantly contributed to increased operating results, restructuring efforts, and exceeded the past five years’ financial, working capital, and operating targets.

Lead M&A efforts for four acquisitions, five divestitures, and several global restructuring efforts, resulting in increased shareholder value.

Lead financial operations that resulted in a +28% CAGR for EBIT over a six-year period.

Implemented new ERP system, pricing, reporting, and contracting methods, yielding efficiency improvements and positive financial results.

TELERX, INC., d/b/a C3i Healthcare, King of Prussia, PA 2015 – 2017

$250+ million wholly owned subsidiary of Merck & Company, Inc., one of the largest pharmaceutical companies in the world. My division consisted of healthcare commercialization services including clinical, medical, and call centers, with up to 4,000 FTEs.

SVP and Global Chief Financial Officer

Managed all areas of Finance, consisting of five divisions and international business units. Directed overall financial policies, overseeing accounting, finance, payroll, credit, tax, and treasury.

This significantly contributed to increased operating results (between +12% and +30%) during each of the past two years, exceeding all financial and operating targets.

Successfully led to the sale of the division to an independent company (sale to HCL Industries).

Lead integration efforts for two acquisitions, including implementing new global ERP system and off shoring functions, reducing costs. Served as a Board of Director on several international business units.

Albert J. Pavucek, Jr., MBA Page 2

PUBLICIS TOUCHPOINT SOLUTIONS, INC., Yardley, PA 2009 – 2015

$350+ million division of Publicis Groupe SA, one of the largest healthcare communications groups in the world. My division consisted of pharmaceutical commercialization services including contract sales forces, clinical, and call centers, with up to 4,000 FTEs.

Chief Financial Officer and Treasurer

Managed all areas of Finance, IT, and Operations, consisting of seven business units. Direct overall financial policies, overseeing accounting, finance, audit, credit, IFRS, and treasury.

Significantly contributed to increased operating results (between +80% and +500%) during each of the past five years; exceeded all financial and operating targets for four consecutive years (with a five-year CAGR of 24%).

Consolidated and aligned several standalone divisions, both US and International, under one cohesive leadership team and company.

Conducted M&A activities, divestitures, and corporate restructuring resulting in increased operating results and shareholder value, and a key driver of contracting and profit-sharing agreements.

Implemented a new ERP system, pricing and contracting methods, yielding efficiency improvements and positive financial results.

ORTHOVITA, INC., Malvern, PA 2006 – 2009

$300 million public medical device manufacturing company.

Chief Financial Officer

Hired to rebuild Finance and IT organizations to support growth and to remediate several material weaknesses and significant deficiencies. This resulted in unqualified audit opinions for three fiscal years, while reducing annual operating costs by $1+ million and improving service levels.

Acted as key senior executive setting business strategy and creating value.

Significantly increased operating results for three continuous years and market cap by ~$125 million.

Led successful company recapitalization effort without an investment banker utilizing $80 million offering, debt facility and royalty obligation buy-outs.

Completed $28 million public stock offering with UBS Securities.

I served as primary contact with Wall Street investment community, attracting simultaneous coverage by 13 sell-side analysts from brokerage firms.

Led sale process to Stryker Medical.

PDI, INC., Saddle River, NJ 2001 – 2006

$400 million public pharmaceutical commercialization partner.

Senior Vice President, Finance and Operations (2002 – 2006)

Divisional Chief Financial Officer, Finance Department (2001 – 2002)

As SVP, responsible for all areas of Finance and Operations, consisting of seven divisions and three segments. Directed overall financial policies, overseeing accounting, finance, budget, credit, SOX, insurance, tax, and treasury.

Increased business unit profitability threefold, year over year, increasing market cap by ~ $150 million.

Created financial projections and forecasts and conducted monthly analysis of operating results, including preparation and review of 10-Qs and 10-K.

Supervised several operational areas, including supply chain, managed markets and trade, and operations.

Performed thorough evaluations of potential investment opportunities and completed acquisitions. Led acquisition, licensing, and integration processes, realizing significant value.

As Divisional CFO, responsible for all areas of Finance and Operations for Pharmaceutical Products Group, a startup division of PDI with product sales of over $500 million, with up to 4,000 FTEs.

Albert J. Pavucek, Jr., MBA Page 3

ASTRAZENECA, LP, Wilmington, DE 1994 – 2001

$18 billion international pharmaceutical company.

Sales Force Controller, Finance Department (1996 – 2001)

Manager, Financial Planning and Analysis (1994 – 1996)

Provided financial advice and counsel to senior sales force management, strategic alliances, and headquarters operations with US sales of $10+ billion and operating budget of $2 billion.

Supported all financial/operational planning, forecasting, and budgeting of sales force; instrumental in managing total year expenses to within 1% of forecast for three consecutive years.

Developed/implemented US synergy targets to increase shareholder value after merger between Astra Pharmaceuticals, LP, and Zeneca Inc.

Major contributor to important projects including several expansions, contract sales force expansion, development of strategic alliance contracts, merger/integration efforts, and strategic plans.

WEST PHARMACEUTICAL SERVICES, INC., Exton, PA 1990 – 1994

NYSE listed $500 million as an international pharmaceutical packaging company.

Finance Manager, Planning and Analysis (1992 – 1994)

International Financial Analyst, International Division (1990 – 1992)

BETZ LABORATORIES, INC., Trevose, PA, now part of General Electric Company 1987 – 1989

NYSE listed $600 million, an international specialty chemical company.

Cost Accounting Manager, Finance Department

E. I. DUPONT DE NEMOURS & CO., INC., Wilmington, DE 1984 – 1987

$30 billion international chemical and oil company.

Financial Accountant, Auditor, Textile Fibers Department

EDUCATION

University of Pennsylvania, Wharton School of Business, Philadelphia, PA

Fellow Alumni, 2003 – 2005

Temple University, Fox School of Business, Philadelphia, PA

Master of Business Administration, 1990

Major: Finance

Temple University, Philadelphia, PA

Bachelor of Business Administration, Summa Cum Laude, 1984

Major: Accounting

President's Scholar: Scholarship Awarded

PROFESSIONAL DEVELOPMENT

University of Pennsylvania Wharton School Executive Education Program,

“The CFO as a Strategic Business Partner Executive”

Passed Pennsylvania CPA Exam, 1986, member of PICPA

AFFILIATIONS

For-Profit Board Member, Generally Eccentric, Inc., and Non-Profit Board member of 1) CFO Alliance, Global Advisory Board, 2) ABB, SE PA, 3) Ocean’s Edge Condominium Association, SIC, NJ, (Treasurer).

Contact this candidate